Evidence map›Paper›PMID 37396621›Full record

ArticleInternational journal of pharmaceutics: X2023

The Dynamic Intestinal Absorption Model (Diamod®), an

Frédéric Moens, Gies Vandevijver, Anke De Blaiser, Adam Larsson, Fabio Spreafico, Patrick Augustijns, Massimo Marzorati

Abstract read
In one paragraph

Article in International journal of pharmaceutics: X, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Frédéric MoensProDigest BV, Technologiepark-Zwijnaarde 73, 9052 Ghent, Belgium.
Gies VandevijverProDigest BV, Technologiepark-Zwijnaarde 73, 9052 Ghent, Belgium.
Anke De BlaiserProDigest BV, Technologiepark-Zwijnaarde 73, 9052 Ghent, Belgium.
Adam LarssonProDigest BV, Technologiepark-Zwijnaarde 73, 9052 Ghent, Belgium.
Fabio SpreaficoProDigest BV, Technologiepark-Zwijnaarde 73, 9052 Ghent, Belgium.
Patrick AugustijnsDrug Delivery and Disposition, KU Leuven, Gasthuisberg O&N II, Herestraat 49 - box 921, Leuven 3000, Belgium.
Massimo MarzoratiProDigest BV, Technologiepark-Zwijnaarde 73, 9052 Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at developing the Diamod® as a dynamic gastrointestinal transfer model with physically interconnected permeation. The Diamod® was validated by studying the impact of the intraluminal dilution of a cyclodextrin-based itraconazole solution and the negative food effect for indinavir sulfate for which clinical data are available demonstrating that the systemic exposure was strongly mediated by interconnected solubility, precipitation, and permeation processes. The Diamod® accurately simulated the impact of water intake on the gastrointestinal behavior of a Sporanox® solution. Water intake significantly decreased the duodenal solute concentrations of itraconazole as compared to no intake of water. Despite this duodenal behavior the amount of permeated itraconazole was not affected by water intake as observed

Indexed as

Diamod®Gastrointestinal dissolutionIndinavir sulfateIntestinal permeationItraconazoleSolubility-permeability interplay

Identifiers

PMID37396621
PMCPMC10314207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.